Literature DB >> 26966828

Quality of life, depression and musculoskeletal pain experience among employed women: A controlled study.

Emre Baskan, Nesrin Yağci, Orçin Telli Atalay, Emine Aslan Telci.   

Abstract

OBJECTIVE: The musculoskeletal pain is one of the leading health problems among employed women. The aim of our study was to examine musculoskeletal pain, depression and quality of life (QOL) among employed women and find out the differences with unemployed women.
METHODS: A hundred and fifty employed women and 151 housewives were included in our study. We used visual analog scale (VAS) for the assessment of pain, Beck Depression Inventory (BDI) for the depressive symptoms and Nottingham Health Profile (NHP) for the assessment of QOL.
RESULTS: The ratio of musculoskeletal pain among employed women and unemployed women were found as 42.5% and 57.5% respectively. A mild level of depression was found among employed women whereas moderate and vigorous level of depression were found among unemployed women. There were significant differences in terms of depression and QOL parameters. When the correlations of pain, depression and QOL were analyzed, significant high positive relationships between spinal, lower extremity, upper extremity pain levels and BDI and NHP were found only in housewives.
CONCLUSIONS: Lower levels of depression among employed women can give the idea that social ambience at work place, focusing at work and economic independence play a role in decreasing depression.

Entities:  

Keywords:  Employed women; depression; musculoskeletal pain

Mesh:

Year:  2016        PMID: 26966828     DOI: 10.3233/BMR-160682

Source DB:  PubMed          Journal:  J Back Musculoskelet Rehabil        ISSN: 1053-8127            Impact factor:   1.398


  1 in total

Review 1.  Chronic Pain in Musculoskeletal Diseases: Do You Know Your Enemy?

Authors:  Roberto Bonanni; Ida Cariati; Virginia Tancredi; Riccardo Iundusi; Elena Gasbarra; Umberto Tarantino
Journal:  J Clin Med       Date:  2022-05-06       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.